Incidental prostate cancer in patients who underwent radical cystectomy for high risk non muscle invasive bladder cancer: Is it clinically significant?. Issue 2 (May 2022)

• Record Type: Journal Article
• Authors: Fragkoulis, Charalampos; Glykas, Ioannis; Mari, Victoria; Lamprou, Stavros; Tzelves, Lazaros; Stathouros, Georgios; Papadopoulos, Georgios; Ntoumas, Konstantinos
• Is Part Of: Urologia journal. Volume 89:Issue 2(2022)
• Page Start: 216
• Page End: 220
• Publication Date: 2022-05
• Subjects: incidental prostate cancer -- clinically significant incidental prostate cancer -- clinically significant incidental prostate cancer in radical cystectomies -- clinically significant incidental prostate cancer in high risk NMIBC; Urology -- Periodicals; 616.6005
• DOI: 10.1177/03915603211019989
• Languages: English
• ISSNs: 0391-5603

Abstract

Introduction and objective: Non muscle invasive, high-risk, bladder cancer is an entity which is usually treated with radical cystectomy. Incidental prostate cancer refers to prostate cancer detected in radical cystectomy specimens in patients with no signs of the disease. Objective of this study is to report the prevalence, characteristics, and clinical significance of incidental prostate cancer in non-muscle invasive bladder cancer patients treated with radical cystectomy in our department. Material and methods: We retrospectively reviewed data from 41 patients who underwent radical cystectomy for non-muscle invasive, high risk, bladder cancer during the years 2016–2020 in our department. Prostate cancer was described as clinically significant when there were positive surgical margins, extraprostatic extension, Gleason score >6, or tumor volume ⩾0.5 cm 3 . Two groups of patients were formed according to the presence or absence of clinically significant prostate cancer. Results: Incidental prostate cancer in the cystectomy specimens was detected in 21 of the 35 patients investigated. Clinically significant prostate cancer was detected in five patients. Positive surgical margins and extraprostatic extension were present in one patient, respectively. Gleason score was more than six in four of the five patients and PCa tumor volume was above 0.5 cm 3 in three patients. Two patients with clinically significant prostate cancer were diagnosed with biochemical recurrence during their follow up. Conclusions: In non-muscle invasive, high-risk patients undergoing radical cystectomy, clinically significant incidental PCa is an important issue as it may affect prognosis, quality of life, metastasis free survival, and overall survival.